Truist Financial maintained a Buy rating on AdaptHealth, noting that the company could benefit from Trump-era tariffs.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial maintained a Buy rating on AdaptHealth, noting that the company could benefit from Trump-era tariffs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AdaptHealth
health care services
Nothing else this week.
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- High-level US and Iranian officials are engaged in talks regarding a nuclear and economic deal, with the IRGC noted as a radical faction.
- Paul Atkins criticized NYC Mayor Mamdani's progressive agenda, while Trump referenced New York's political direction, coinciding with SEC jurisdiction issues in Manhattan.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyTruist Financial Remains Bullish on AdaptHealth (AHCO) AdaptHealth Corp. (NASDAQ:AHCO) is one of the best undervalued medical device stocks to buy now. In a report released on July 1, David S Macdona